{"id":732593,"date":"2023-02-17T08:42:25","date_gmt":"2023-02-17T13:42:25","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-caribou-biosciences-inc-nasdaq-crbu-investors-of-securities-class-action-lawsuit-and-upcoming-lead-plaintiff-deadline\/"},"modified":"2023-02-17T08:42:25","modified_gmt":"2023-02-17T13:42:25","slug":"lowey-dannenberg-notifies-caribou-biosciences-inc-nasdaq-crbu-investors-of-securities-class-action-lawsuit-and-upcoming-lead-plaintiff-deadline","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-caribou-biosciences-inc-nasdaq-crbu-investors-of-securities-class-action-lawsuit-and-upcoming-lead-plaintiff-deadline\/","title":{"rendered":"Lowey Dannenberg Notifies Caribou Biosciences, Inc. (Nasdaq: CRBU) Investors of Securities Class Action Lawsuit and Upcoming Lead Plaintiff Deadline"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NEW YORK, Feb.  17, 2023  (GLOBE NEWSWIRE) &#8212; Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Caribou Biosciences, Inc.\u00a0(Nasdaq: CRBU) (\u201cCaribou\u201d or the \u201cCompany\u201d) for violations of the federal securities laws on behalf of investors who purchased or otherwise acquired: (a) Caribou common stock pursuant and\/or traceable to documents issued in connection with the Company\u2019s initial public offering (\u201cIPO\u201d) conducted on or about July 23, 2021; and\/or (b) Caribou securities between July 23, 2021, and December 9, 2022 (the \u201cClass Period\u201d).<\/p>\n<p>On February 10, 2023, a complaint was filed against Caribou and certain of its officers and directors alleging that the IPO Offering Documents were negligently prepared and, as a result, contained untrue statements of material fact or omitted to state other facts necessary to make the statements made not misleading and were not prepared in accordance with the rules and regulations governing their preparation. Additionally, throughout the Class Period, Caribou made materially false and misleading statements regarding the company\u2019s business, operations, and prospects. Specifically, the Offering Documents and Caribou made false and\/or misleading statements and\/or failed to disclose that: (i) CB-010\u2019s treatment effect was not as durable as Caribou had led investors to believe; (ii) accordingly, CB-010\u2019s clinical and commercial prospects were overstated; and (iii) as a result, the Offering Documents and Caribou\u2019s public statements throughout the Class Period were materially false and\/or misleading and failed to state information required to be stated therein.<\/p>\n<p>When investors learned the truth, Caribou\u2019s common stock declined precipitously, injuring investors.<\/p>\n<p>If you suffered a loss in Caribou\u2019s securities, and wish to participate, or learn more, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=psm-kDbiVca_hKrMK_nBh68jiN_ntakT9vgqQgQyTtVuUTIuxFBlLWl6bl1FL8hfKRdZs5udDse-Db1WIDkH7GiLZe-SZKiMVlgoCmsnkJw=\" rel=\"nofollow noopener\" target=\"_blank\">click here<\/a>, or please contact our attorneys at (914) 733-7234 or via email at investigations@lowey.com.<\/p>\n<p>Any investor who wishes to serve as Lead Plaintiff must act before April 11, 2023.<\/p>\n<p>\n        <strong>About Lowey Dannenberg<\/strong><br \/>\n        <br \/>Lowey Dannenberg is a national firm representing institutional and individual investors, who suffered financial losses resulting from corporate fraud and malfeasance in violation of federal securities and antitrust laws. The firm has significant experience in prosecuting multi-million-dollar lawsuits and has recovered billions of dollars on behalf of its clients.<\/p>\n<p>\n        <strong>Contact<\/strong>:<br \/>Lowey Dannenberg P.C.<br \/>44 South Broadway, Suite 1100<br \/>White Plains, NY 10601<br \/>Tel: (914) 733-7234<br \/>Email: investigations@lowey.com<\/p>\n<p>\n        <strong>SOURCE<\/strong>: Lowey Dannenberg P.C.<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc1MTg0OSM1NDE2NTAxIzIxOTQ1MzQ=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/N2NhZDViNzgtYTM5MC00NDY1LWFhNGMtYTNiZWNjNzJmNWNiLTEyMDYwODc=\/tiny\/Lowey-Dannenberg-P-C-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, Feb. 17, 2023 (GLOBE NEWSWIRE) &#8212; Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Caribou Biosciences, Inc.\u00a0(Nasdaq: CRBU) (\u201cCaribou\u201d or the \u201cCompany\u201d) for violations of the federal securities laws on behalf of investors who purchased or otherwise acquired: (a) Caribou common stock pursuant and\/or traceable to documents issued in connection with the Company\u2019s initial public offering (\u201cIPO\u201d) conducted on or about July 23, 2021; and\/or (b) Caribou securities between July 23, 2021, and December 9, 2022 (the \u201cClass Period\u201d). On February 10, 2023, a complaint was filed against Caribou and certain of its officers and directors alleging that the IPO Offering Documents were &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-caribou-biosciences-inc-nasdaq-crbu-investors-of-securities-class-action-lawsuit-and-upcoming-lead-plaintiff-deadline\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Lowey Dannenberg Notifies Caribou Biosciences, Inc. (Nasdaq: CRBU) Investors of Securities Class Action Lawsuit and Upcoming Lead Plaintiff Deadline&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-732593","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Lowey Dannenberg Notifies Caribou Biosciences, Inc. (Nasdaq: CRBU) Investors of Securities Class Action Lawsuit and Upcoming Lead Plaintiff Deadline - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-caribou-biosciences-inc-nasdaq-crbu-investors-of-securities-class-action-lawsuit-and-upcoming-lead-plaintiff-deadline\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lowey Dannenberg Notifies Caribou Biosciences, Inc. (Nasdaq: CRBU) Investors of Securities Class Action Lawsuit and Upcoming Lead Plaintiff Deadline - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Feb. 17, 2023 (GLOBE NEWSWIRE) &#8212; Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Caribou Biosciences, Inc.\u00a0(Nasdaq: CRBU) (\u201cCaribou\u201d or the \u201cCompany\u201d) for violations of the federal securities laws on behalf of investors who purchased or otherwise acquired: (a) Caribou common stock pursuant and\/or traceable to documents issued in connection with the Company\u2019s initial public offering (\u201cIPO\u201d) conducted on or about July 23, 2021; and\/or (b) Caribou securities between July 23, 2021, and December 9, 2022 (the \u201cClass Period\u201d). On February 10, 2023, a complaint was filed against Caribou and certain of its officers and directors alleging that the IPO Offering Documents were &hellip; Continue reading &quot;Lowey Dannenberg Notifies Caribou Biosciences, Inc. (Nasdaq: CRBU) Investors of Securities Class Action Lawsuit and Upcoming Lead Plaintiff Deadline&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-caribou-biosciences-inc-nasdaq-crbu-investors-of-securities-class-action-lawsuit-and-upcoming-lead-plaintiff-deadline\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-17T13:42:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc1MTg0OSM1NDE2NTAxIzIxOTQ1MzQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-caribou-biosciences-inc-nasdaq-crbu-investors-of-securities-class-action-lawsuit-and-upcoming-lead-plaintiff-deadline\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-caribou-biosciences-inc-nasdaq-crbu-investors-of-securities-class-action-lawsuit-and-upcoming-lead-plaintiff-deadline\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Lowey Dannenberg Notifies Caribou Biosciences, Inc. (Nasdaq: CRBU) Investors of Securities Class Action Lawsuit and Upcoming Lead Plaintiff Deadline\",\"datePublished\":\"2023-02-17T13:42:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-caribou-biosciences-inc-nasdaq-crbu-investors-of-securities-class-action-lawsuit-and-upcoming-lead-plaintiff-deadline\\\/\"},\"wordCount\":403,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-caribou-biosciences-inc-nasdaq-crbu-investors-of-securities-class-action-lawsuit-and-upcoming-lead-plaintiff-deadline\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc1MTg0OSM1NDE2NTAxIzIxOTQ1MzQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-caribou-biosciences-inc-nasdaq-crbu-investors-of-securities-class-action-lawsuit-and-upcoming-lead-plaintiff-deadline\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-caribou-biosciences-inc-nasdaq-crbu-investors-of-securities-class-action-lawsuit-and-upcoming-lead-plaintiff-deadline\\\/\",\"name\":\"Lowey Dannenberg Notifies Caribou Biosciences, Inc. (Nasdaq: CRBU) Investors of Securities Class Action Lawsuit and Upcoming Lead Plaintiff Deadline - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-caribou-biosciences-inc-nasdaq-crbu-investors-of-securities-class-action-lawsuit-and-upcoming-lead-plaintiff-deadline\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-caribou-biosciences-inc-nasdaq-crbu-investors-of-securities-class-action-lawsuit-and-upcoming-lead-plaintiff-deadline\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc1MTg0OSM1NDE2NTAxIzIxOTQ1MzQ=\",\"datePublished\":\"2023-02-17T13:42:25+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-caribou-biosciences-inc-nasdaq-crbu-investors-of-securities-class-action-lawsuit-and-upcoming-lead-plaintiff-deadline\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-caribou-biosciences-inc-nasdaq-crbu-investors-of-securities-class-action-lawsuit-and-upcoming-lead-plaintiff-deadline\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-caribou-biosciences-inc-nasdaq-crbu-investors-of-securities-class-action-lawsuit-and-upcoming-lead-plaintiff-deadline\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc1MTg0OSM1NDE2NTAxIzIxOTQ1MzQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc1MTg0OSM1NDE2NTAxIzIxOTQ1MzQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lowey-dannenberg-notifies-caribou-biosciences-inc-nasdaq-crbu-investors-of-securities-class-action-lawsuit-and-upcoming-lead-plaintiff-deadline\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lowey Dannenberg Notifies Caribou Biosciences, Inc. (Nasdaq: CRBU) Investors of Securities Class Action Lawsuit and Upcoming Lead Plaintiff Deadline\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lowey Dannenberg Notifies Caribou Biosciences, Inc. (Nasdaq: CRBU) Investors of Securities Class Action Lawsuit and Upcoming Lead Plaintiff Deadline - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-caribou-biosciences-inc-nasdaq-crbu-investors-of-securities-class-action-lawsuit-and-upcoming-lead-plaintiff-deadline\/","og_locale":"en_US","og_type":"article","og_title":"Lowey Dannenberg Notifies Caribou Biosciences, Inc. (Nasdaq: CRBU) Investors of Securities Class Action Lawsuit and Upcoming Lead Plaintiff Deadline - Market Newsdesk","og_description":"NEW YORK, Feb. 17, 2023 (GLOBE NEWSWIRE) &#8212; Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Caribou Biosciences, Inc.\u00a0(Nasdaq: CRBU) (\u201cCaribou\u201d or the \u201cCompany\u201d) for violations of the federal securities laws on behalf of investors who purchased or otherwise acquired: (a) Caribou common stock pursuant and\/or traceable to documents issued in connection with the Company\u2019s initial public offering (\u201cIPO\u201d) conducted on or about July 23, 2021; and\/or (b) Caribou securities between July 23, 2021, and December 9, 2022 (the \u201cClass Period\u201d). On February 10, 2023, a complaint was filed against Caribou and certain of its officers and directors alleging that the IPO Offering Documents were &hellip; Continue reading \"Lowey Dannenberg Notifies Caribou Biosciences, Inc. (Nasdaq: CRBU) Investors of Securities Class Action Lawsuit and Upcoming Lead Plaintiff Deadline\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-caribou-biosciences-inc-nasdaq-crbu-investors-of-securities-class-action-lawsuit-and-upcoming-lead-plaintiff-deadline\/","og_site_name":"Market Newsdesk","article_published_time":"2023-02-17T13:42:25+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc1MTg0OSM1NDE2NTAxIzIxOTQ1MzQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-caribou-biosciences-inc-nasdaq-crbu-investors-of-securities-class-action-lawsuit-and-upcoming-lead-plaintiff-deadline\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-caribou-biosciences-inc-nasdaq-crbu-investors-of-securities-class-action-lawsuit-and-upcoming-lead-plaintiff-deadline\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Lowey Dannenberg Notifies Caribou Biosciences, Inc. (Nasdaq: CRBU) Investors of Securities Class Action Lawsuit and Upcoming Lead Plaintiff Deadline","datePublished":"2023-02-17T13:42:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-caribou-biosciences-inc-nasdaq-crbu-investors-of-securities-class-action-lawsuit-and-upcoming-lead-plaintiff-deadline\/"},"wordCount":403,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-caribou-biosciences-inc-nasdaq-crbu-investors-of-securities-class-action-lawsuit-and-upcoming-lead-plaintiff-deadline\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc1MTg0OSM1NDE2NTAxIzIxOTQ1MzQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-caribou-biosciences-inc-nasdaq-crbu-investors-of-securities-class-action-lawsuit-and-upcoming-lead-plaintiff-deadline\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-caribou-biosciences-inc-nasdaq-crbu-investors-of-securities-class-action-lawsuit-and-upcoming-lead-plaintiff-deadline\/","name":"Lowey Dannenberg Notifies Caribou Biosciences, Inc. (Nasdaq: CRBU) Investors of Securities Class Action Lawsuit and Upcoming Lead Plaintiff Deadline - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-caribou-biosciences-inc-nasdaq-crbu-investors-of-securities-class-action-lawsuit-and-upcoming-lead-plaintiff-deadline\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-caribou-biosciences-inc-nasdaq-crbu-investors-of-securities-class-action-lawsuit-and-upcoming-lead-plaintiff-deadline\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc1MTg0OSM1NDE2NTAxIzIxOTQ1MzQ=","datePublished":"2023-02-17T13:42:25+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-caribou-biosciences-inc-nasdaq-crbu-investors-of-securities-class-action-lawsuit-and-upcoming-lead-plaintiff-deadline\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-caribou-biosciences-inc-nasdaq-crbu-investors-of-securities-class-action-lawsuit-and-upcoming-lead-plaintiff-deadline\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-caribou-biosciences-inc-nasdaq-crbu-investors-of-securities-class-action-lawsuit-and-upcoming-lead-plaintiff-deadline\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc1MTg0OSM1NDE2NTAxIzIxOTQ1MzQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc1MTg0OSM1NDE2NTAxIzIxOTQ1MzQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lowey-dannenberg-notifies-caribou-biosciences-inc-nasdaq-crbu-investors-of-securities-class-action-lawsuit-and-upcoming-lead-plaintiff-deadline\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Lowey Dannenberg Notifies Caribou Biosciences, Inc. (Nasdaq: CRBU) Investors of Securities Class Action Lawsuit and Upcoming Lead Plaintiff Deadline"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/732593","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=732593"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/732593\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=732593"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=732593"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=732593"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}